Low molecular weight heparin versus minidose unfractionated heparin for prophylaxis against venous thromboembolism in medical intensive care unit patients: A randomized controlled trial

被引:0
|
作者
Goldhaber, SZ
Kett, DH
Cusumano, CJ
Kuroki, CA
机构
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页码:325A / 325A
页数:1
相关论文
共 50 条
  • [1] Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma
    Jacobs, Benjamin N.
    Cain-Nielsen, Anne H.
    Jakubus, Jill L.
    Mikhail, Judy N.
    Fath, John J.
    Regenbogen, Scott E.
    Hemmila, Mark R.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2017, 83 (01): : 151 - 158
  • [2] Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients
    Rothberg, Michael B.
    Pekow, Penelope S.
    Lahti, Maureen
    Lindenauer, Peter K.
    JOURNAL OF HOSPITAL MEDICINE, 2012, 7 (06) : 457 - 463
  • [3] Low-molecular-weight heparin versus unfractionated heparin for prophylaxis of venous thromboembolism in medicine patients: a pharmacoeconomic analysis
    Wilbur, Kerry
    Lynd, Larry
    Sadatsafavi, Mohsen
    PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 266 - 266
  • [4] Low-molecular-weight Heparin (enoxaparin) versus unfractionated heparin for venous thromboembolism prophylaxis in patients undergoing craniotomy
    Kandula, Viswajit
    Shah, Parth, V
    Thirunavu, Vineeth M.
    Yerneni, Ketan
    Karras, Constantine
    Abecassis, Zachary A.
    Hopkins, Benjamin
    Bloch, Orin
    Potts, Matthew B.
    Jahromi, Babak S.
    Tate, Matthew C.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2022, 223
  • [5] Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis: a randomized controlled trial
    Misra, U. K.
    Kalita, J.
    Chandra, S.
    Kumar, B.
    Bansal, V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (07) : 1030 - 1036
  • [6] Comparison of low-molecular-weight heparin and unfractionated heparin for venous thromboembolism prophylaxis in trauma patients
    Gowler, Aimee
    Erstad, Brian
    Tang, Andrew
    PHARMACOTHERAPY, 2013, 33 (05): : E52 - E52
  • [7] Venous Thromboembolism Prophylaxis with Enoxaparin Versus Unfractionated Heparin in Patients with Low Body Weight
    Kaylor, David Michael
    Wade, Regan Merrell
    Chappell, Kathryn Brinkley
    Niemann, Meredith Huff
    VanArsdale, Vanessa Marie
    PLASMATOLOGY, 2023, 17
  • [8] Low-Molecular-Weight Heparin Versus Unfractionated Heparin for Prophylaxis of Venous Thromboembolism in Medicine Patients-A Pharmacoeconomic Analysis
    Wilbur, Kerry
    Lynd, L. D.
    Sadatsafavi, M.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2011, 17 (05) : 454 - 465
  • [9] Transaminase elevation in patients treated with unfractionated heparin or low molecular weight heparin for venous thromboembolism
    Girolami, B
    Prandoni, P
    Rossi, L
    Girolami, A
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1998, 4 (02) : 126 - 128
  • [10] Prescription of low molecular weight heparin (LMWH) for prophylaxis against venous thromboembolism (VTE) in medical patients
    Wardle, J
    Webb, J
    Holmes, J
    Myers, B
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 7 - 7